Role of prostaglandins in neuroinflammatory and neurodegenerative diseases
- PMID: 22778499
- PMCID: PMC3385693
- DOI: 10.1155/2012/946813
Role of prostaglandins in neuroinflammatory and neurodegenerative diseases
Abstract
Increasing data demonstrates that inflammation participates in the pathophysiology of neurodegenerative diseases. Among the different inflammatory mediators involved, prostaglandins play an important role. The effects induced by prostaglandins might be mediated by activation of their known receptors or by nonclassical mechanisms. In the present paper, we discuss the evidences that link prostaglandins, as well as the enzymes that produce them, to some neurological diseases.
References
-
- Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nature Medicine. 2004;10:S18–S25. - PubMed
-
- Craft JM, Watterson DM, Van Eldik LJ. Neuroinflammation: a potential therapeutic target. Expert Opinion on Therapeutic Targets. 2005;9(5):887–900. - PubMed
-
- Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer’s disease. Glia. 1993;7(1):75–83. - PubMed
-
- Hoozemans JJ, Chafekar SM, Baas F, Eikelenboom P, Scheper W. Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer’s disease. Current Medicinal Chemistry. 2006;13(22):2599–2605. - PubMed
-
- McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology. 1988;38(8):1285–1291. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical